SCHEMBL5777232

SCHEMBL5777232

CCOC(=O)c1c[nH]nc1Cc1ccccc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
AR P10275 1/20 0.46
TSHR P16473 1/20 0.44
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
ALDH1A1 P00352 2/20 0.43
CACNA1C Q13936 2/20 0.43
POLB P06746 1/20 0.41
EPHX2 P34913 3/20 0.40
HSD17B10 Q99714 2/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
RECQL P46063 1/20 0.40
PPARG P37231 2/20 0.40
CACNA1F O60840 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
POLQ O75417 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5779565 0.85 L3MBTL1 (0.48) KDM4EARTSHRALDH1A1POLB
SCHEMBL5778710 0.79 SMN1; SMN2 (0.52) KDM4ETSHRALDH1A1POLBHSD17B10
SCHEMBL29026435 0.78 MAPT (0.49) KDM4EALDH1A1
SCHEMBL5055900 0.76 KDM4E (0.48) KDM4EALDH1A1
SCHEMBL29025464 0.76 TSHR (0.41) KDM4ETSHRALDH1A1
SCHEMBL1994129 0.75 TSHR (0.67) KDM4ETSHRALDH1A1CACNA1CHSD17B10
SCHEMBL7512080 0.75 TSHR (0.50) KDM4ETSHRALDH1A1POLBHSD17B10
SCHEMBL3356162 0.74 KMT2A (0.49) KDM4ETSHRALDH1A1HSD17B10MAPK1
SCHEMBL5779014 0.73 PDE3B (0.49) KDM4ETSHRPOLBMAPK1
SCHEMBL69229 0.73 KDM4E (0.54) KDM4ETSHRALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2006-07-12 EP disclosed
WO-2005042534-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2005-05-12 WO disclosed